Cirm Grant (Details) - USD ($) $ in Thousands |
1 Months Ended | 6 Months Ended | |
|---|---|---|---|
Nov. 30, 2020 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Cirm Grant [Line Items] | |||
| Other research and development | $ 2,300 | ||
| Percentage of licensing fees | 0.10% | ||
| Percentage of converted loan | 60.00% | ||
| Received from interest rate | 25.00% | ||
| Received aggregate from CIRM | $ 2,300 | ||
| CIRM grant received in other non-current liabilities | $ 2,264 | ||
| Other income | 2,300 | ||
| CIRM [Member] | |||
| Cirm Grant [Line Items] | |||
| Net sales | $ 1,000 | ||
| CIRM grant received in other non-current liabilities | $ 2,300 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Represent of net sales. No definition available.
|
| X | ||||||||||
- Definition The 25% rule can be used as a starting point for valuing and setting fair royalty rates for intellectual property assets including copyrights, trademarks and patents in licensing deals. It is an example of an income-based approach licensing fees. No definition available.
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. No definition available.
|
| X | ||||||||||
- Definition Dividend or interest rate associated with the financial instrument issued in exchange for the original debt being converted in a noncash or part noncash transaction. Noncash are transactions that affect recognized assets or liabilities but that do not result in cash receipts or cash payments. Part noncash refers to that portion of the transaction not resulting in cash receipts or cash payments. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Rate of interest on investment. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue and income classified as other. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|